5-fluoro-1-methyl-1H-indole-2-carbaldehyde, 95.0%, 500mg

Sodium pyrimidine-2-sulfinate, 98.0%, 250mg

2-amino-1-(1H-indol-3-yl)ethanone hydrochloride, 95.0%, 250mg

5-Bromo-1,2-dichloro-3-nitrobenzene, 98%, 100mg

4-Bromofuran-3-carboxylic acid, 98%, 100mg

4-Oxo-4-pyrrolidin-1-yl-butyric acid, 98.0%, 2g

2-(3-Pyridylamino)-1,3-thiazole-4-carboxylic acid, 95%, 1g

5-Chloro-2-methyl-1H-pyrrolo[3,2-b]pyridine, 95.0%, 500mg

Sulfuric acid, 95-98%, Ph.Eur., 1L, glass packaging

Ethyl (1S,2R)-1-{[(tert-butoxy)carbonyl]amino}-2-ethenylcyclopropane-1-carboxylate, 97.0%, 1g

(R)-4-(tert-Butyl)-2-(pyrimidin-2-yl)-4,5-dihydrooxazole, 97%, 250mg

Methacrylic acid methyl ester, 25 l, tinplate

Hydroxyvalerenic acid, with analyt. Documents, 100 mg, glass packaging